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Background
A large number of therapeutically relevant proteins,
including secreted enzymes, hormones and neuropep-
tides, need post-translational proteolytic processing to
become mature and functional. A problem in their heter-
ologous expression is often represented by the limited
ability of the host cell to efficiently and accurately mature
the recombinantly expressed zymogens and precursors.
This hurdle often impairs their expression level and solu-
bility, and an in vitro maturation step is always required to
recover functionally active products. However, the latter
procedure cannot be universally applied, since in many
cases functional enzymes can be obtained only when the
post-translational processing is accomplished by the
physiological peptidase in the proper cell compartment.
Results
To tackle this bottleneck in recombinant protein produc-
tion, we have developed an insect cell line able to process
inactive zymogens. Stably transfected cells have been iso-
lated through serial limiting dilutions and clone pool
analysis has been performed to ensure the expression of
the recombinant gene. Functional screening has been
applied to characterize the final clones, based on the abil-
ity of the cells infected with recombinant baculovirus to
secrete properly processed human enzymes. The selected
clone was demonstrated to be competent for processing of
different enzyme classes, including lipase, serine
endopeptidase and metalloprotease. The processing
extent of the secreted enzymes strictly correlated with an
increase in their catalytic activity, confirming that cleavage
occurred at the proper activation site. The final validation
was performed applying a high-throughput approach,
whereby media of insect cells grown in 24-deep-well
blocks were processed using a 96-well plate fully-auto-
mated robotic procedure to purify the recombinant pro-
teins, whose catalytic activity was assayed in 384-well
plate format with a homogeneous fluorescence-based rea-
dout. Pro-protein processing stably transfected cells were
easily adapted to grow in miniaturized format (2 ml in 24-
deep-well block) and were used for mid-scale production
of a recombinant human peptidase, demonstrating good
compliance with different cultivation conditions.
Conclusion
We have developed a novel stably transfected insect cell
line able to effectively process recombinant pro-contain-
ing proteins.
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